We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > allergic conjunctivitis

News List

Vanda Receives FDA Approval to Proceed with VSJ-110 for Allergic Conjunctivitis americanpharmaceuticalreview
November 02, 2020
Vanda Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to evaluate Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) activator VSJ-110 (previously known as ...
Aldeyra Announces Last Patient Dosed in the ALLEVIATE Trial americanpharmaceuticalreview
December 21, 2018
Aldeyra Therapeutics announced the last patient has completed dosing in the ALLEVIATE Phase 3 clinical trial of topical ocular reproxalap in patients with allergic conjunctivitis....